Pliant Therapeutics Inc (PLRX) Stock Price, Quote & News

Company Profile

Pliant Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases. The company's lead candidate includes bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which has completed phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonal...

Industry: Biotechnology

Sector: Healthcare

Phone: 650 481 6770

Website: pliantrx.com

Address:

331 Oyster Point Boulevard, South San Francisco, United States

DARKP00L Aug. 13 at 3:19 PM

$PLRX this stock is attracting a lot of interest. Be prepared for possible changes!

0 · Reply

JarvisFlow Aug. 8 at 11:31 AM

Piper Sandler has adjusted their stance on Pliant Therapeutics ( $PLRX ), setting the rating to Overweight with a target price of 17 → 4.

0 · Reply

Sholtzc Aug. 6 at 7:48 PM

$PLRX What a twisted pos

0 · Reply

Bellbent Aug. 5 at 1:59 PM

$PLRX sold, bringing my money over to $SSKN, been a sweet ride from 1.11 Pliant. Thank you!

0 · Reply

MrCodyHUN Aug. 5 at 11:37 AM

$PLRX I sold, good luck for everyone! I still think it has room to move

0 · Reply

mcrotary Aug. 4 at 7:33 PM

$PLRX grabbed

0 · Reply

jjmo1491 Aug. 4 at 6:42 PM

$PLRX im out of here, this will probably keep going up over next couple weeks though! $ADVM $RCKT here we come

0 · Reply

jjmo1491 Aug. 4 at 3:55 PM

$PLRX just get to 1.75 and my plan is done 🙏

4 · Reply

MrCodyHUN Aug. 4 at 2:36 PM

$PLRX if this can finally get through the 1.6 range (failed on it four times in the past), then it will fly.

0 · Reply

MrCodyHUN Aug. 1 at 6:17 PM

$PLRX looks like a clear W formation...

0 · Reply

Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results

Jun 27, 2025, 4:05 PM EDT - 7 weeks ago

Pliant Therapeutics Provides Update on BEACON-IPF

May 21, 2025, 4:03 PM EDT - 3 months ago

Pliant Therapeutics Presents Clinical and Preclinical Data at the American Thoracic Society International Conference

May 8, 2025, 4:05 PM EDT - 3 months ago

Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results

May 1, 2025, 4:05 PM EDT - 3 months ago

Pliant Therapeutics Announces Strategic Realignment of Workforce and Operations

Apr 7, 2025, 4:05 PM EDT - 4 months ago

Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference

Apr 3, 2025, 12:22 PM EDT - 4 months ago

Pliant Therapeutics: An Activist On Deck

$Pliant Therapeutics Announces Interim Phase 1 Data for PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors$

Mar 17, 2025, 8:00 AM EDT - 5 months ago

Pliant Therapeutics Announces Interim Phase 1 Data for PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors

Mar 13, 2025, 11:04 AM EDT - 5 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics

Mar 13, 2025, 7:20 AM EDT - 5 months ago

Pliant Therapeutics Adopts Limited Duration Stockholder Rights Agreement

Mar 3, 2025, 4:05 PM EST - 6 months ago

Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2024 Financial Results

Mar 3, 2025, 1:32 PM EST - 6 months ago

Pliant Therapeutics Stock Sinks, Discontinues Mid-Stage Study For Lung Disorder

Mar 3, 2025, 9:27 AM EST - 6 months ago

Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis

Mar 2, 2025, 11:00 AM EST - 6 months ago

The Schall Law Firm Invites Shareholders With Losses In Pliant Therapeutics, Inc. To Join A Securities Fraud Investigation

Feb 27, 2025, 10:00 AM EST - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Pliant Therapeutics, Inc. (PLRX) Shareholders to Inquire about Securities Investigation

Feb 26, 2025, 10:00 AM EST - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Pliant Therapeutics, Inc. (PLRX) And Encourages Shareholders to Connect

Feb 25, 2025, 10:00 AM EST - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Pliant Therapeutics, Inc. (PLRX) And Encourages Shareholders to Reach Out

Feb 24, 2025, 10:00 AM EST - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pliant Therapeutics, Inc. (PLRX) and Encourages Shareholders to Learn More About the Investigation

Feb 23, 2025, 10:00 AM EST - 6 months ago

Pliant Therapeutics, Inc. (PLRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Feb 21, 2025, 10:00 AM EST - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Pliant Therapeutics, Inc. (PLRX) And Encourages Investors to Connect

Feb 20, 2025, 3:39 PM EST - 6 months ago

PLRX Investors Have Opportunity to Join Pliant Therapeutics, Inc. Fraud Investigation with the Schall Law Firm

Feb 20, 2025, 10:00 AM EST - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Pliant Therapeutics, Inc. (PLRX) Stockholders to Inquire about Securities Investigation

Feb 19, 2025, 10:00 AM EST - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pliant Therapeutics, Inc. (PLRX) and Encourages Investors to Learn More About the Investigation

Feb 18, 2025, 10:00 AM EST - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pliant Therapeutics, Inc. (PLRX) and Encourages Stockholders to Learn More About the Investigation

Feb 17, 2025, 10:00 AM EST - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Pliant Therapeutics, Inc. (PLRX) Investors to Inquire about Securities Investigation

Feb 16, 2025, 10:00 AM EST - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Pliant Therapeutics, Inc. (PLRX) And Encourages Investors to Reach Out

DARKP00L Aug. 13 at 3:19 PM

$PLRX this stock is attracting a lot of interest. Be prepared for possible changes!

0 · Reply

JarvisFlow Aug. 8 at 11:31 AM

Piper Sandler has adjusted their stance on Pliant Therapeutics ( $PLRX ), setting the rating to Overweight with a target price of 17 → 4.

0 · Reply

Sholtzc Aug. 6 at 7:48 PM

$PLRX What a twisted pos

0 · Reply

Bellbent Aug. 5 at 1:59 PM

$PLRX sold, bringing my money over to $SSKN, been a sweet ride from 1.11 Pliant. Thank you!

0 · Reply

MrCodyHUN Aug. 5 at 11:37 AM

$PLRX I sold, good luck for everyone! I still think it has room to move

0 · Reply

mcrotary Aug. 4 at 7:33 PM

$PLRX grabbed

0 · Reply

jjmo1491 Aug. 4 at 6:42 PM

$PLRX im out of here, this will probably keep going up over next couple weeks though! $ADVM $RCKT here we come

0 · Reply

jjmo1491 Aug. 4 at 3:55 PM

$PLRX just get to 1.75 and my plan is done 🙏

4 · Reply

MrCodyHUN Aug. 4 at 2:36 PM

$PLRX if this can finally get through the 1.6 range (failed on it four times in the past), then it will fly.

0 · Reply

MrCodyHUN Aug. 1 at 6:17 PM

$PLRX looks like a clear W formation...

0 · Reply

Fib7867 Jul. 25 at 4:58 PM

Blame #Canada 1999 The 51 state. #TheFUTURE *2025 $HTZ $WLGS $PLRX

1 · Reply

Bellbent Jul. 24 at 3:47 PM

$SSKN $PLRX $NAUT $QSI In biogem we trust!

0 · Reply

Bellbent Jul. 24 at 2:16 PM

$QSI Still crossing my fingers on a 1.20 entry! Made great money flipping $NAUT and $PLRX as of late. Currently hifing in $SSKN all thanks to @BioGem

0 · Reply

Fib7867 Jul. 23 at 4:41 PM

When you start to profit the brokers start to collect your identity. $WLGS $WINT $PLRX

1 · Reply

Fib7867 Jul. 18 at 3:17 PM

#myPLRXanalysis $PLRX

0 · Reply

Bellbent Jul. 17 at 3:39 PM

$PLRX see you on Monday, news is coming!

0 · Reply

Bellbent Jul. 17 at 2:48 PM

$PLRX shorts moving the price, will not be holding over the weekend. Accumulating

0 · Reply

Bellbent Jul. 17 at 1:38 AM

$PLRX did I miss something, was there 700k shares traded AH?

0 · Reply

wavw Jul. 16 at 1:52 AM

$PLRX did they resume trial or still analyzing

0 · Reply

Bellbent Jul. 15 at 8:03 PM

$PLRX https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-plrx/pliant-therapeutics/news/3-promising-penny-stocks-with-market-caps-under-200m-2/amp

0 · Reply

WaterWings Jul. 13 at 3:18 PM

$PLRX

0 · Reply

BestNwest Jul. 12 at 3:10 AM

$PLRX the train ride his ride up again,unstoppable

0 · Reply

Market Cap	95.15M
Revenue (ttm)	0.00
Net Income (ttm)	-210.30M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.14

Volume	847,096
Avg Vol	1,311,082
Day's Range	N/A - N/A
Shares Out	61.39M
Stochastic %K	41%
Beta	1.42
Analysts	Sell
Price Target	$2.96